Companies › XBIT

XBiotech Inc (XBIT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001626878 · EDGAR filings · Updated 2026-05-14

XBiotech Inc (XBIT) has reported institutional ownership of 6.5%, with 37 institutional managers holding positions valued at $4.68M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Latest updates

• 2026-05-14 — Quarterly report (10-Q) filed
• 2026-04-29 — 10-K/A filed
• 2026-03-13 — Annual report (10-K) filed
• 2026-03-11 — Employee-plan registration (S-8) filed
• 2026-01-23 — SCHEDULE 13G/A filed
• 2026-01-23 — SCHEDULE 13G/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, XBiotech Inc has 37 institutional holders and institutional ownership of 6.5%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

ELECTROCORE INC (ECOR) · SPECTRAL AI INC (MDAI) · NASUS PHARMA LTD (NSRX) · HYPERION DEFI INC (HYPD) · Senti Biosciences Inc (SNTI) · VolitionRx Limited (VNRX)